-
Family Matters: Why Genetic Cancer Testing is Important
24 Oct 2025 21:30 GMT
When someone in your family is diagnosed with cancer, it can raise questions. Is it a coincidence, or is there something that runs in the family that makes others more likely to get it too?<hr /><p><small>Original article published at …
-
GC Genome unveils upgraded ai-CANCERCH early cancer test
24 Oct 2025 02:05 GMT
… clinical value of its early cancer test, ai-CANCERCH, with the medical …
-
<![CDATA[Epigenetics company donates cancer tests to HOPE AACR ]]>
23 Oct 2025 22:01 GMT
… donated its Nu.Q Vet Cancer Test to support canines providing both … donating the Nu.Q Vet Cancer Test. The screening test is accessible … tests like Nu.Q Vet Cancer Test. For dogs over 7, certain …
-
Breast cancer tests, signature pink car come to Ruler Foods
23 Oct 2025 10:05 GMT
… up to bring free breast cancer testing, along with other important women …
-
Free health screenings, cancer tests at Kota Sentosa Health Clinic this Nov 8
23 Oct 2025 03:13 GMT
Facebook
Twitter
LinkedIn
Threads
WhatsApp
Telegram
(From left) Jennet, Yap and clinic medical officer Aizat Ruslin in a photo call, taken during the press conference.
KUCHING (Oct 23): About 200 participants are expected to join the Kota Sentosa Health …
-
UK start-up Procyon has pancreatic cancer test in its sights
22 Oct 2025 13:11 GMT
A UK start-up, Procyon Diagnostics, has spun out of Queen Mary University of London with a mission to deliver tests that can spot cancer in the early stages, when treatment has the best chance of working.
The company has been launched to develop a …
-
ProPhase Labs Announces Study Validating BE-Smart Esophageal Cancer Test Accepted by Journal of Clinical Gastroenterology and Hepatology
22 Oct 2025 11:30 GMT
… ) validating the BE-Smart™ esophageal cancer test has been accepted for publication … commercializing our BE-Smart Esophageal Cancer Test, our expectations regarding future liquidity …
-
PD-1 Inhibition in Pancreatic Cancer: Testing Insights
21 Oct 2025 23:54 GMT
Recent advancements in oncology have unveiled a pressing need to explore the intricacies of immune checkpoint inhibitors, particularly focusing on PD-1 inhibition in specific cancer types. One such focus has emerged in the context of pancreatic ductal …
-
Samsung partners with Grail in $110 M deal to expand early cancer testing across Asia
21 Oct 2025 11:31 GMT
… M deal to expand early cancer testing across Asia
October 21, 2025 …
-
Oncology Molecular Diagnostics Market Set to Hit $6.46B by 2033 Amid AI & Liquid Biopsy Surge
24 Oct 2025 13:04 GMT
… 's TruSight™ Oncology Comprehensive test for cancer genomic profiling received regulatory approval …